NCT02917954 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Bayliss EA, Bosworth HB, Noel PH, Wolff JL, Damush TM, Mciver L
Supporting self-management for patients with complex medical needs: recommendations of a working group. Chronic Illn. 2007 Jun;3(2):167-75.
Commission on the Reform of Ontario's Public Services, Public Services for Ontarians: A Path to Sustainability and Excellence
2012.
Department of Health, Long Term Conditions Compedium of Information, Third Edition, D
o. Health, Editor. 2012: United Kingdom.
Emanuel EJ
Where are the health care cost savings? JAMA. 2012 Jan 4;307(1):39-40. doi: 10.1001/jama.2011.1927.
Heslop L, Athan D, Gardner B, Diers D, Poh BC
An analysis of high-cost users at an Australian public health service organization. Health Serv Manage Res. 2005 Nov;18(4):232-43.
Marengoni A, Angleman S, Melis R, Mangialasche F, Karp A, Garmen A, Meinow B, Fratiglioni L
Aging with multimorbidity: a systematic review of the literature. Ageing Res Rev. 2011 Sep;10(4):430-9. doi: 10.1016/j.arr.2011.03.003. Epub 2011 Mar 23. Review.
Reid R, Evans R, Barer M, Sheps S, Kerluke K, McGrail K, Hertzman C, Pagliccia N
Conspicuous consumption: characterizing high users of physician services in one Canadian province. J Health Serv Res Policy. 2003 Oct;8(4):215-24.
Rosella LC, Fitzpatrick T, Wodchis WP, Calzavara A, Manson H, Goel V
High-cost health care users in Ontario, Canada: demographic, socio-economic, and health status characteristics. BMC Health Serv Res. 2014 Oct 31;14:532. doi: 10.1186/s12913-014-0532-2.

Full Evaluation, Scale and Spread: Pragmatic Trial of the HSPRN-Bridgepoint Electronic Patient Reported Outcome (ePRO) Mobile Application to Support the Needs of Persons With Complex Chronic Disease and Disability

Details for clinical trial NCT02917954

Clinical trial NCT02917954 - References